Delivery Order SPE2DE21D7010-SPE2D625F4CX7

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $41K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
This federal contract award, valued at $29,781.18, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of January 31, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award, valued at $46,038.63, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, with a period of performance ending on March 17, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is part of a larger $8 million Blanket...
This federal contract award is for $20,821.36 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a delivery order with a fixed price plus economic price adjustment pricing type, and has an ultimate completion date of January 31, 2025. The contract does not have a set-aside designation, indicating Nuvasive, Inc. competed for the award in an open market...
This federal contract award, valued at $17,360.46, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of February 21, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and operates as a for-profit...
This federal contract award is a delivery order (SPE2DE21D7010|SPE2D625F0N6K) valued at $31,469.80 issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract provides a range of spinal medical devices and surgical instruments to support orthopedic, neurological, and reconstructive surgeries at...
This federal contract award, valued at $4,745.79, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, provides a range of advanced spinal implants, instruments, biologics, and related surgical equipment to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract...
  • SPE2DE21D7010
    Indefinite Delivery Contract
  • SPE2DE21D7010-SPE2D625F4CX7
    Delivery Order

This federal contract award is for $40,819.90 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of June 30, 2025.

Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is not associated with any set-aside designation, indicating Nuvasive competes successfully in open market procurements. The contract is for the delivery of Nuvasive's specialized spinal medical technologies, implants, instruments, biologics, and related surgical equipment to support the Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA) healthcare systems. Nuvasive also holds a significant $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle through March 2027, allowing DHA and VA medical facilities to efficiently access Nuvasive's portfolio of spinal medical devices and instruments.

Generated 9/26/25, 9:45 AM